Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Steve Miller Insider Profile
11 Followers
Steve Miller, Chief Op. & Scientific Officer at Catalyst Pharma, holds 922.00K shares in Catalyst Pharma (Ticker: CPRX).
Steve Miller Catalyst Pharma (CPRX)Chief Op. & Scientific Officer
Catalyst Pharma (CPRX)
Chief Op. & Scientific Officer
Ranked #64,679 out of 99,797 Corporate Insiders
Profitable Transactions
4 out of 8 Profitable Transactions
Average Return
-6.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Op. & Scientific Officer
Roles that Steve Miller holds in companies
Most Profitable Insider Trade
The most profitable trade made by Steve Miller
Steve Miller's Trading History
List of latest transactions for each holding click on a transaction to see Steve Miller's performance on stock
You May Also Like
Steve Miller insider profile FAQ
What is the percentage of profitable transactions made by Steve Miller?
The percentage of profitable transactions made by Steve Miller is 50%.
What is the average return per transaction made by Steve Miller?
The average return per transaction made by Steve Miller is -6.70%.
What stocks does Steve Miller hold?
Steve Miller holds: CPRX stocks.
What was Steve Miller’s latest transaction?
Steve Miller latest transaction was an Uninformative Buy of $942.35K.
What was Steve Miller's most profitable transaction?
Steve Miller’s most profitable transaction was an Informative Buy of CPRX stock on June 4, 2014. The return on the trade was 79.60%.
What is Steve Miller's role in Catalyst Pharma?
Steve Miller's role in Catalyst Pharma is Chief Op. & Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.